1160.20.10013 — New Hyde Park, New York

1160.20.10013 is a clinical research site located in New Hyde Park, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

1160.20.10013 has participated in 1 clinical trials.

Therapeutic areas: Atrial Fibrillation.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1160.20.10013?

1160.20.10013 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1160.20.10013 conducted?

1160.20.10013 has 1 clinical trials on record. Their work covers Atrial Fibrillation.

Is 1160.20.10013 accredited by Crixeo Health?

1160.20.10013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1160.20.10013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.